Occidental Petroleum Announces 2017 Results and 2018 Guidance
Get Alerts OXY Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.8%
Revenue Growth %: +11.9%
Join SI Premium – FREE
HOUSTON, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Occidental Petroleum Corporation (NYSE: OXY) today announced its 2017 results and 2018 guidance. The announcement, financial schedules and accompanying slides can be accessed via the Investor Relations section of the company’s website, www.oxy.com. The earnings release is also available on the Securities and Exchange Commission's website at www.sec.gov.
The company will hold a conference call on Wednesday, February 14, 2018, at 11 a.m. Eastern/10 a.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at www.oxy.com/investors.
A recording of the webcast will be posted on the Investor Relations section of the website within several hours after the call is completed.
About Occidental Petroleum
Occidental Petroleum Corporation is an international oil and gas exploration and production company with operations in the United States, Middle East and Latin America. Headquartered in Houston, Occidental is one of the largest U.S. oil and gas companies, based on equity market capitalization. Occidental’s midstream and marketing segment gathers, processes, transports, stores, purchases and markets hydrocarbons and other commodities. The company’s wholly owned subsidiary OxyChem manufactures and markets basic chemicals and vinyls. Occidental posts or provides links to important information on its website at www.oxy.com.
Contacts: Media: Melissa E. Schoeb 713-366-5615 [email protected] or Investors: Richard A. Jackson 713-215-7235[email protected] On the web: www.oxy.com
Source: Occidental Petroleum CorporationSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Middleby board approves spin-off of food processing unit Midera
- Masimo gets FDA clearance for opioid respiratory risk detection
- Taysha completes dosing in Rett syndrome pivotal trial, reports data
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share